Atypical neuropathological sCJD-MM phenotype with abundant white matter Kuru-type plaques sparing the cerebellar

Ellen Gelpi1, Josep Ma Soler Insa, Piero Parchi

  • 1Neurological Tissue Bank of the Biobank-Hospital Clinic-IDIBAPS, Facultat de Medicina, Spain. ellen.gelpi@gmail.com

Insights

This study details an unusual case of sporadic Creutzfeldt-Jakob disease (sCJD) with Kuru-type plaques and co-existing prion protein types, highlighting diagnostic complexities.

Area of Science:

  • Neuropathology
  • Prion Diseases
  • Neurodegenerative Disorders

Background:

  • Sporadic Creutzfeldt-Jakob disease (sCJD) is a fatal prion disease characterized by rapidly progressive dementia.
  • Typical neuropathological findings include spongiform changes and prion protein (PrP) deposits.
  • Classification of sCJD subtypes relies on molecular and histopathological features.

Observation:

  • A 64-year-old man presented with rapidly progressive dementia and atypical MRI findings.
  • Neuropathology revealed classical CJD changes alongside abundant Kuru-type plaques, particularly in white matter.
  • Immunohistochemistry and Western blot showed co-existing PrP(res) types 1 and 2.

Findings:

  • The case presented a unique combination of histopathological features, including widespread Kuru-type plaques in cerebral white matter.
  • This phenotype did not fit current sCJD classification criteria.
  • Co-occurrence of PrP(res) types 1 and 2 was confirmed in the frontal cortex.

Implications:

  • This case expands the known histopathological spectrum of sporadic Creutzfeldt-Jakob disease.
  • It underscores the complexity of prion protein isotype and histopathological phenotype correlations.
  • Highlights the need for comprehensive diagnostic approaches in atypical prion disease presentations.

Related Concept Videos

Alzheimer Disease ll: Pathophysiology01:23

Alzheimer Disease ll: Pathophysiology

Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...
Huntington Disease l: Introduction01:21

Huntington Disease l: Introduction

Huntington disease or HD is a progressive, fatal neurodegenerative disorder inherited in an autosomal dominant pattern.PathophysiologyIt is caused by expansion of the CAG trinucleotide repeat in the HTT gene on chromosome 4 (4p16.3), producing an abnormal huntingtin protein with an expanded polyglutamine tract. This misfolded protein disrupts cellular function, leading to neuronal death. Normal alleles have ≤26 repeats, 27–35 are intermediate (risk of expansion), 36–39 show reduced penetrance,...
Parkinson Disease ll: Pathophysiology01:24

Parkinson Disease ll: Pathophysiology

Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
Alzheimer Disease l: Introduction01:29

Alzheimer Disease l: Introduction

Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
Cerebral Edema ll: Pathophysiology01:22

Cerebral Edema ll: Pathophysiology

Vasogenic edema is a major form of cerebral edema characterized by abnormal accumulation of fluid in the brain’s extracellular space due to disruption of the blood–brain barrier (BBB). The BBB is a specialized structure composed of endothelial cells connected by tight junctions, supported by astrocytic endfeet and a basement membrane. Under normal conditions, it tightly regulates the movement of ions, proteins, and solutes between the bloodstream and brain parenchyma. When this barrier loses...